Rapid Recovery in COVID-19 Patients with Chronic Hepatitis B Virus Infection Treated with Tenofovir Disoproxil Fumarate.

Xiliu Chen Di LiuDongliang YangXin Zheng

Published in: Journal of clinical and translational hepatology (2021)

The coronavirus disease 2019 (COVID-19) pandemic continues worldwide. We report here two cases of chronic hepatitis B patients with acute respiratory syndrome coronavirus 2 infection treated with tenofovir disoproxil fumarate who demonstrated a favorable outcome. This report adds some evidence that concurrent HBV infection may not worsen COVID-19 infection and tenofovir disoproxil fumarate treatment may have partial positive effect on COVID-19 rapid recovery.

Keyphrases

coronavirus disease
respiratory syndrome coronavirus
sars cov
hepatitis b virus
antiretroviral therapy
loop mediated isothermal amplification
newly diagnosed
locally advanced
combination therapy
squamous cell carcinoma
radiation therapy
replacement therapy
quantum dots
liver fibrosis